TissueVision

Somerville, United States Founded: 2005 • Age: 21 yrs
Whole organ and tissue imaging and analysis services are offered.
Request Access

About TissueVision

TissueVision is a company based in Somerville (United States) founded in 2005.. TissueVision offers products and services including TissueCyte, SlicePlacer, and Custom Assays. TissueVision operates in a competitive market with competitors including Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others.

  • Headquarter Somerville, United States
  • Sectors
    Healthcare
  • Email
    ***********
  • Phone
    *********
  • Website
    *********
  • Social
    *********
  • Legal Name Tissuevision India Private Limited
  • Date of Incorporation 13 Mar, 2023
  • Jurisdiction Bangalore North, Karnataka, India
Operational Areas
Healthcare → Biotechnology, Genomics & Life Sciences Research
Healthcare → Healthcare Services & Infrastructure
Key Metrics
  • Annual Revenue
  • Net Profit
  • EBITDA
  • Latest Funding Round
    $2.49 M (USD), Grant

    Aug 15, 2023

  • Investors
    HHS

    & 1 more

  • Employee Count
    Employee Count
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • Full access to every database India & global coverage, advanced filters and rich profile details
  • Always-on access from your team account Single premium plan for everything you see on the portal

Products & Services of TissueVision

TissueVision offers a comprehensive portfolio of products and services, including TissueCyte, SlicePlacer, and Custom Assays. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.

Primary

Delivers high-resolution 3D imaging for whole organ studies

Automates tissue section processing for research applications

Develops tailored assays for specific tissue analysis needs

People of TissueVision
Headcount 10-50
Employee Profiles 2
Employee Profiles
People
Tim Ragan
CEO and Founder
People
Yan Seng Elijah Yew
Director of Imaging Hardware

Unlock access to complete

Teams

Unlock access to complete

Funding Insights of TissueVision

  • Total Funding
  • Total Rounds 14
  • Last Round Grant — $2.5M
  • First Round

    (04 Aug 2008)

  • Investors Count 2
Date Amount Transaction Name Valuation Lead Investors Investors
Aug, 2023 Amount Grant - TissueVision Valuation

investors

HHS
Sep, 2022 Amount Grant - TissueVision Valuation

investors

HHS
Sep, 2021 Amount Grant - TissueVision Valuation

investors

HHS
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Investors in TissueVision

TissueVision has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include HHS and NIH SBIR/STTR. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.

All
Venture Fund
Institutional
Investor Description Founded Year Domain Location
-
Founded Year Domain Location
Public health and human services are overseen by HHS.
Founded Year Domain Location
Investor Description Founded Year Domain Location
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
Founded Year Domain Location
Startup ecosystems are ignited through strategic investments by Signite Partners.
Founded Year Domain Location
Venture capital is directed toward companies in multiple sectors.
Founded Year Domain Location
Venture capital is invested in cybersecurity, fintech, and AI startups.
Founded Year Domain Location

Investments & Acquisitions by TissueVision

Investments
Company Name Description Domain Location Founded Year Amount
Bionic investment advisor platform
2016
Fine Asian gourmet food is offered by an internet-first restaurant.
2016
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
2014
Fine Asian gourmet food is offered by an internet-first restaurant.
2016

Financial Statements - TissueVision

Tata Steel revenue growth over time
Tata Steel profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Jan, 2021 Amount Post-IPO - Grab Valuation

investors

Feb, 2021 Amount Post-IPO - Grab Valuation

investors

Tissuevision Comparisons

Employees
+
Add Comparison
Available on Premium

Competitors of TissueVision

TissueVision operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Bio Rad, Siemens Healthineers, Merck, Quanterix and Biocare Medical, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.

Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Portfolio of products and services for life science research and clinical diagnostic markets
domain founded_year HQ Location
AI-based medical diagnostics are developed for healthcare applications.
domain founded_year HQ Location
Merck is engaged in science and technology solutions globally.
domain founded_year HQ Location
Assay kits for ultra-sensitive biomarker detection are developed.
domain founded_year HQ Location
Primary antibodies and instruments for immunohistochemistry are manufactured.
domain founded_year HQ Location
Tissue hypothermic storage and cryopreservation freeze media are developed.
Company Name Domain Founded year HQ Location Description
domain founded_year HQ Location
Multiple services are booked via an app-based platform.
domain founded_year HQ Location
On-demand services are booked through an app-based platform.
domain founded_year HQ Location
App based platform offering on demand delivery and ride-hailing services
domain founded_year HQ Location
Operates an on-demand hyperlocal delivery app for food and groceries.

Latest news on Tissuevision

Frequently Asked Questions about TissueVision

When was TissueVision founded?

TissueVision was founded in 2005 and raised its 1st funding round 3 years after it was founded.

Where is TissueVision located?

TissueVision is headquartered in Somerville, United States. It is registered at Somerville, Massachusetts, United States.

What does TissueVision do?

Founded in 2005 and based in Somerville, United States, TissueVision operates as a contract research organization in the biomedical sector. Preclinical animal models are imaged and analyzed at the whole organ and tissue level using patented technology for automated, high-throughput fluorescence imaging. Multispectral biochemical signatures are captured sub-micron resolution. Turn-key packages convert raw samples into comprehensive reports, enabling evaluation of disease models and treatment profiles with clinically relevant biomarkers.

Who are the top competitors of TissueVision?

TissueVision's top competitors include Biocare Medical, Merck and Siemens Healthineers.

What products or services does TissueVision offer?

TissueVision offers TissueCyte, SlicePlacer, and Custom Assays.

Who are TissueVision's investors?

TissueVision has 2 investors. Key investors include HHS, and NIH SBIR/STTR.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available